|
|
 |
|
Polish Academy of Sciences
Institute of Immunology and Experimental Therapy
Centre of Excellence since October 2002
|
 |
 |
 |
 |
|
wersja polska
 |
International Bioethical Conference
”The responsible conduct of basic and clinical research”
June 3-4, 2005, Warsaw
|
GENERAL INFORMATION
- Conference Venue
International Centre of Biocybernetics
02-109 Warsaw
4 Trojdena Street
Poland
- Scientific Committee
Ks. Prof. W. Bołoz
Prof. A. Górski (chair)
Prof. M.W. Grabski
Prof. T. Tołłoczko
Contact: agorski@ikp.pl
Under the auspices of the Minister of Science, the Minister of Health, and Division VI - Medical Sciences, Polish Academy of Sciences,
in collaboration with the Office of Research Integrity, US Department of Health and Human Services
and Association of the Pharmaceutical Companies Representatives in Poland
- Organizing Secretariat
“CONGRESS-OR”
Congress & Tourism Bureau
47 Żurawia Street, Apt. 304
00-680 Warsaw
tel./fax. ( + 48 22 ) 621-31-16 ; 628 45 48
e-mail: d.korpaczewska@congressor.com.pl
PROGRAM
To view a presentation, please click on its title.
All rights of the author or authors of the presentation are reserved and anyone who uses the presentations agrees to acknowledge the author and the author's institution.
June 3, 2005
| 9:00 | Opening ceremony |
SESSION I (Chairs: Pieter Drenth, All European Academies, The Netherlands; Eero Vuorio, Finnish Natl. Advisory Board on Res. Ethics)
|
| 9:30 – 10:00 | What Constitutes Responsible Conduct of Research, Nicholas Steneck, Office of Research Integrity; University of Michigan, USA |
| 10:00 – 10:30 | Scientific Integrity and The Role of Academies of Science, Pieter Drenth, President, All European Academies, The Netherlands |
| 10:30 – 11:00 | Authorship and Publication Practices, Michael J.G. Farthing, St George’s Hospital Medical School, Univ of London, UK |
| 11:00 – 11:20 | Discussion |
| 11:20 – 11:30 | Break |
| 11:30 – 12:00 | Data Management, Chris Pascal, Office of Research Integrity, USA |
| 12:00 – 12:30 | Discussion |
| 12:30 – 13:30 | Lunch |
SESSION II (Chairs: Zbigniew Szawarski, University of Warsaw, PL; Eugenijus Gefenas, Medical Faculty, University of Vilnius, LT)
|
| 13:30 – 14:00 | Towards Greater Transparency of Clinical Research - An IFPMA Perspective, Maciej Gajewski, International Association of Pharmaceutical Manufacturers & Associations, Geneva, CH |
| 14:00 – 14:30 | Peer Review, David Wright, Michigan State Univ, USA |
| 14:30 – 15:00 | Discussion |
| 15:00 – 15:15 | Break |
| 15:15 – 16:00 | Collaborative Research, Howard Gadlin, Ombudsman, National Institutes of Health, USA |
| 16:00 – 16:45 | Discussion |
| 16:45 – 17:30 |
The Handling of Research Misconduct Allegations, Chris Pascal, Office of Research Integrity, USA;
Pitfalls in Clinical Research, Piotr Zaborowski, The Medical University of Warsaw, PL
|
| 17:30 – 18:00 | Discussion |
June 4, 2005
SESSION III (Chairs: Marie Charlotte Bouesseau, World Health Organization, Switzerland; Andrzej Górski, Committee on Ethics in Science, Ministry of Science/Bioethics Commission, Ministry of Health, PL)
|
| 9:00 – 9:45 |
Mentor – Trainee Relationships, David Wright, Michigan State University, USA;
Mentor and Trainee in Clinical Academic Medicine, Tadeusz Tolloczko, Warsaw, PL
|
| 9:45 – 10:15 | Discussion |
| 10:15 – 10:45 | Establishing a Responsible Conduct of Research Program, Nicholas Steneck, Office of Research Integrity; University of Michigan, USA |
| 10:45 – 11:05 | Discussion |
| 11:05 – 11:20 | Break |
| 11:20 – 11:50 | Institutionalizing Ethics: The Mission, Function, and Responsibilities of Research Ethics Committees, Marie – Charlotte Bouesseau, Ethics, Trade, Human Rights and Health Law, World Health Organization, CH |
| 11:50 – 12:10 | Discussion |
| 12:10 – 12:55 |
Protection of Animal Research Subjects, Czeslaw Radzikowski, International Council of Laboratory Animal Science, PL;
Ethical and Welfare Aspects of Animal Experimentation, Roman Kolar, Deputy Director, Animal Welfare Academy, German Animal Welfare Federation, D;
Human Rights vs. Animal Rights: How to Apply ‘Humane Treatment’ in Animal Research, Ioana Ispas, European Integration Councellor for Bioethics, Genomics and Health, Ministry of European Integration, Bucharest, RO
|
| 12:55 – 13:25 | Discussion |
| 13:25 – 14:30 | Lunch |
SESSION IV (Chairs: Melody Lin, US Department of Health; John Williams, World Medical Association)
|
| 14:30 - 15:45 | Protection of human research subjects
Research Protections and Research Enterprise – Melody Lin, US Dept of Health and Human Services;
The Physician's Role in The Protection of Human Research Subjects – John Williams, World Medical Association, Geneva, CH;
Biomedical Research, Globalization and The Commerce: The Need for Special Protection of The Poor – R.R.Kishore, President, Indian Society for Health, Laws, and Ethics, New Delhi, India
|
| 15:45 – 16:15 | Discussion |
| 16:15 – 16:30 | Break |
| 16:30 - 18:00 |
Communications
(Chairs: Hans-Joerg Ehni, University of Tuebingen, Germany; Svetlana Pustovit, Kiev, Ukraine)
- The Definition of Adequate Care in Externally Sponsored Clinical Trials, Hans-Joerg Ehni, University of Tuebingen, Germany
- The Concept of Quality in Clinical Research, Dorota Switula, Senior CQA Advisor, AstraZeneca Global Clinical Quality Assurance, AstraZeneca Pharma, Poland
- Concept of Risk and Ethical Review of Biomedical Research, Eugenijus Gefenas, The Medical Faculty, University of Vilnius, Lithuania
- Evaluation of Drug Toxicity in Clinical Trials: a Biased Misconception, Jacek Splawinski, National Institute of Public Health, Poland
- Patient Safety in Clinical Research, Marek Labon, Director of Therapeutics, Academic Clinical Center, The Medical University of Gdansk, Poland
- Patient Protection in Clinical Trials, Marek Czarkowski, Bioethics Commission, Warsaw Chamber of Physicians, Poland
- Ethical Expertise in The Ukraine, Svetlana Pustovit, President, The Ukrainian Association on Bioethics, Kiev, Ukraine
|
| 18:00 – 18:30 | Discussion |
| 18:30 | Summary and Conclusions, Ray Spier, Editor, Science & Engineering Ethics
|
|
|
|
|
